C. Deng

发表

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

Martin Röcken, Susanne Feil, Robert Feil, 2012 .

Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.

A. Lovett-racke, M. Racke, P. D. Drew, 2002, Journal of immunology.

Prevalence of Barrett Esophagus in First-Degree Relatives of Patients With Esophageal Adenocarcinoma

A. Chak, H. Lynch, S. Mittal, 2011, Journal of clinical gastroenterology.

Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion.

P. Abel, Yan Xie, Y. Tu, 2013, Biochemical pharmacology.

ToleranceAcetylcholine Receptor T Cell Epitope Clonal Anergy Involved in Systemic Fas/Fas Ligand Pathway, Apoptosis, and

P. Christadoss, E. Goluszko, C. Deng, 2001 .

Fas/Fas Ligand Pathway, Apoptosis, and Clonal Anergy Involved in Systemic Acetylcholine Receptor T Cell Epitope Tolerance

P. Christadoss, E. Goluszko, C. Deng, 2001 .

Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis

P. Christadoss, A. Lovett-racke, M. Racke, 2003, Journal of Neuroimmunology.

Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis

P. Christadoss, E. Goluszko, M. Poussin, 2002, Journal of Neuroimmunology.

Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in Mice

P. Christadoss, N. Sarvetnick, L. Bradley, 1997, The Journal of experimental medicine.

-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis

A. Lovett-racke, M. Racke, P. D. Drew, 2002 .

IL-1 Receptor-Associated Kinase 1 Regulates Susceptibility to Organ-Specific Autoimmunity

C. Radu, M. Racke, C. Deng, 2003 .

Susceptibility to Organ-Specific IL-1 Receptor-Associated Kinase 1 Regulates

C. Radu, M. Tsen, James A. Thomas, 2003 .

Autoimmune Myasthenia Gravis the Progression of Antibody-Dependent The Th 2 Cytokine IL-4 Is Not Required for and

P. Christadoss, N. Sarvetnick, C. Deng, 1998 .

This information is current as Formation and C3 Production Associated with Reduced Germinal Center Myasthenia Gravis in IL-6-Deficient Mice Is Resistance to Experimental Autoimmune

P. Christadoss, E. Goluszko, E. Tüzün, 2013 .

Resistance to Experimental Autoimmune Myasthenia Gravis in IL-6-Deficient Mice Is Associated with Reduced Germinal Center Formation and C3 Production1

P. Christadoss, E. Goluszko, E. Tüzün, 2002, The Journal of Immunology.

Role of nerve growth factor in experimental autoimmune encephalomyelitis

D. Holtzman, A. Lovett-racke, M. Racke, 2001, European journal of immunology.

A Giant Cystic Pheochromocytoma of the Adrenal Gland

Poonam K Sharma, Zenggang Pan, S. Repertinger, 2008, Endocrine pathology.

Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways.

Y. Yen, R. Recker, V. Go, 2010, Journal of proteome research.

Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis1

A. Lovett-racke, M. Racke, Bounleut Phanavanh, 2002, The Journal of Immunology.

Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4.

T. Wei, P. Abel, Yan Xie, 2009, Cancer research.

Phosphoinositide 3-Kinase γ Regulates Airway Smooth Muscle Contraction by Modulating Calcium Oscillations

T. Casale, P. Abel, Yan Xie, 2010, Journal of Pharmacology and Experimental Therapeutics.

Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer

R. Recker, Z. Gatalica, Yingchun Zhao, 2011, Breast Cancer Research and Treatment.

Fas/Fas Ligand Pathway, Apoptosis, and Clonal Anergy Involved in Systemic Acetylcholine Receptor T Cell Epitope Tolerance1

P. Christadoss, E. Goluszko, C. Deng, 2001, The Journal of Immunology.

Antigen-Specific Immunointervention in Experimental Myasthenia Gravis

P. Christadoss, C. Deng, 2000 .

Animal models of myasthenia gravis.

P. Christadoss, M. Poussin, C. Deng, 2000, Clinical immunology.

Lymphotoxin-alpha deficiency completely protects C57BL/6 mice from developing clinical experimental autoimmune myasthenia gravis

P. Christadoss, E. Goluszko, P. Hjelmström, 2001, Journal of Neuroimmunology.

Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis1

E. Ward, A. Minguela, C. Radu, 2002, The Journal of Immunology.

The Role of Costimulation in Experimental Autoimmune Encephalomyelitis

A. Lovett-racke, R. Stuart, M. Racke, 2005 .

IL-1 Receptor-Associated Kinase 1 Regulates Susceptibility to Organ-Specific Autoimmunity1

C. Radu, M. Tsen, James A. Thomas, 2003, The Journal of Immunology.

Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.

P. Christadoss, E. Goluszko, C. Deng, 1997, Journal of immunology.

miR-221 suppresses ICAM-1 translation and regulates interferon-gamma-induced ICAM-1 expression in human cholangiocytes.

Guoku Hu, Xian-Ming Chen, C. Deng, 2010, American journal of physiology. Gastrointestinal and liver physiology.

A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion

P. Watson, C. Deng, V. Rao, 2011, Oncogene.

let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer

R. Recker, Z. Gatalica, Yingchun Zhao, 2011, Molecular medicine.

Epigenetic repression of regulator of G‐protein signaling 2 promotes androgen‐independent prostate cancer cell growth

Z. Gatalica, P. Abel, Yan Xie, 2012, International journal of cancer.

Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.

M. Shenoy, P. Christadoss, R. Kaul, 1997, Journal of Immunology.

The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.

P. Christadoss, N. Sarvetnick, J. Lee, 1998, Journal of immunology.

Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in Mice

P. Christadoss, N. Sarvetnick, L. Bradley, 1997, The Journal of experimental medicine.

The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis.

P. Christadoss, E. Goluszko, C. Deng, 1998, Clinical immunology and immunopathology.

miR‐141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein

C. Young, Xian-Ming Chen, C. Deng, 2012, The Prostate.

IFN-α Therapy Is Effective in Suppressing the Clinical Experimental Myasthenia Gravis

P. Christadoss, S. Baron, E. Goluszko, 1996 .

MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer

R. Recker, Z. Gatalica, Yingchun Zhao, 2011 .

Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion.

P. Abel, Yan Xie, Y. Tu, 2013, Biochemical pharmacology.

An Oncocytoma Associated With Acquired Cystic Disease of Kidney: A Case Report and Review of the Literature

Zenggang Pan, C. Deng, E. Adickes, 2008 .

Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4.

T. Wei, P. Abel, Yan Xie, 2009, Cancer research.

A Large Esophageal Granular Cell Tumor with Review of Literature

S. Mittal, C. Deng, Jeff F. Wang, 2011 .